user

Effect of paricalcitol on biochemical markers of secondary hyperparathyroidism in hemodialysis patients

被引：0
|
作者：
Zdravkovic, J. [3 ]
Georgijev, D. Ristic [3 ]
Zdravkovic, A. [5 ]
Zdravkovic, K. [2 ]
Popovic, M. [4 ]
Stojanovic, S. [1 ]
机构：
[1] Hlth Ctr Vranje, Dept Anesthesia, Novi Beograd, Serbia
[2] Hlth Ctr Vranje, Daily Chemiotherapy Hosp, Novi Beograd, Serbia
[3] Hlth Ctr Vranje, Dept Lab Med, Novi Beograd, Serbia
[4] Hlth Ctr Vranje, Dept Nephrol, Novi Beograd, Serbia
[5] Univ Nis, Fac Med, Nish, Serbia
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.118623
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P0747
引用
收藏
页数：1
相关论文
共 50 条
  • [41] SECONDARY HYPERPARATHYROIDISM IN ELDERLY HEMODIALYSIS PATIENTS
    Vakhitova, Renata
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [42] Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism
    Hoshino, H
    Kushida, K
    Takahashi, M
    Denda, M
    Yamazaki, K
    Yamanashi, A
    Inoue, T
    [J]. MINERAL AND ELECTROLYTE METABOLISM, 1997, 23 (02) : 93 - 99
  • [43] Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover study
    Mittman, N.
    Khanna, R.
    Rani, S.
    Chattopadhyay, J.
    Avram, M. M.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 : S64 - S67
  • [44] Effects of Oral Paricalcitol on Secondary Hyperparathyroidism and Proteinuria of Kidney Transplant Patients
    Gonzalez, Esther
    Rojas-Rivera, Jorge
    Polanco, Natalia
    Morales, Enrique
    Maria Morales, Jose
    Egido, Jesus
    Amado, Andres
    Praga, Manuel
    [J]. TRANSPLANTATION, 2013, 95 (07) : E49 - E52
  • [45] Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study
    Koc, Hasan
    Hoser, Hasan
    Akdag, Yalcin
    Kendir, Cemaliye
    Ersoy, F. Fevzi
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (07) : 1261 - 1270
  • [46] The Impact of Paricalcitol on Parathyroid Gland Size of Secondary Hyperparathyroidism Patients with Long-Term Maintenance Hemodialysis: An Observational Study
    Tao, Chenghui
    Liao, Xiaohui
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 210 - 210
  • [47] Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism
    Gafor, Abdul Halim Abdul
    Saidin, Rashidi
    Yean, Loo Chee
    Mohd, Rozita
    Zainudin, Soehardy
    Shah, Shamsul Azhar
    Tong, Norella Kong Chiew
    [J]. NEPHROLOGY, 2009, 14 (05) : 488 - 492
  • [48] EFFICACY AND SAFETY OF INTRAVENOUS PARICALCITOL TREATMENT IN CHINESE HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM: A REAL-WORLD DATABASE ANALYSIS
    Wang, Niansong
    Jiang, Gengru
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1745 - 1745
  • [49] Treatment of secondary hyperparathyroidism with paricalcitol in patients with end-stage renal disease undergoing hemodialysis in Turkey: an observational study
    Hasan Koc
    Hasan Hoser
    Yalcin Akdag
    Cemaliye Kendir
    F. Fevzi Ersoy
    [J]. International Urology and Nephrology, 2019, 51 : 1261 - 1270
  • [50] Reducing hyperparathyroidism in African-American hemodialysis patients using paricalcitol.
    Crawford, P
    Sobrero, M
    Shott, S
    Deering, A
    Young, T
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) : A15 - A15
12345